UNSPSC 51285308: Furaltadone

This classification denotes an anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5X4V82ZN30. European Medicines Agency schedules Furaltadone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07831MIG. Furaltadone generally arises in the molecular formula C13H16N4O6.

UNSPSC 51285308 Furaltadone is a Commodity code for a specific veterinary antimicrobial pharmaceutical product, yet the recent state and local procurement activity tagged under this code shows no alignment with the code's nominal scope. The two recent opportunities on record — an Illinois Department of Public Health piggyback pharmaceutical warehouse contract awarded to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, and a Seminole County, Florida IFB for Naloxone and Safe Drug Deactivation Systems — involve human pharmaceutical products and emergency medical supplies, not veterinary antimicrobials. State and local procurement offices appear to be tagging these opportunities with this Furaltadone code in error or using it as a catch-all category within broader pharmaceutical procurement workflows.

The Illinois contract, awarded at $2,999,999.11 over three years including renewals, represents a state health department's routine pharmaceutical supply needs through a cooperative purchasing vehicle (MMCAP Infuse). The Seminole County opportunity, an IFB with a July 26, 2023 response deadline, sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually via quarterly deliveries. Neither opportunity reflects demand for the specific drug this code nominates. Given the mismatch between the code's intended scope and actual recent procurement activity, this code shows little relevant recent activity for vendors supplying Furaltadone or similar veterinary antimicrobial products to state and local government.